Call Today

+91 76889 29292

Open Hour

2:00 PM - 08:00 PM

About Doctor

Dr. Anup Toshniwal

MBBS ., GMC, Ch.Sambhaji Nagar 

M.D. (Medicine), D.M. (Medical Oncology)

Tata Memorial Mumbai

ECMO (European Society of Medical Oncologist.

ACORD(Australian Clinical Oncology Research Fellow)

Consultant Oncologist & Hemato – Oncologist

Dr. Anup Toshniwal is an Experienced Cancer Doctor in Aurangabad. He has completed his M.D. Medicine from Kasturba Medical College, Mangalore, and DM Medical Oncology from Tata Memorial Hospital, Mumbai. He has done an MBBS from Government Medical College, Aurangabad. He has extensive experience in the diagnosis and management of all types of cancers, all hematological cancers, as well as procedures such as bone marrow biopsy, lumbar puncture, etc. Dr. Anup Toshniwal is well known Cancer Specialist in Aurangabad.

Education & Experience

  •  Assistant professor at (Tata Memorial Hospital, Mumbai)
  •  Associate Professor At Government Cancer Hospital, Aurangabad
  •  Teaching experience for DM (Medical Oncology) & MD (Medicine) Courses.

NATIONAL & INTERNATIONAL PUBLICATIONS

  • Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients who are intolerant/unsuitable for Ganciclovir Therapy.
  •  Downstaging with Neoadjuvant Chemotherapy in locally advanced gall bladder cancers, Improves Outcomes, annals of Oncology.
  • Toxicity and early outcomes of Regorafenib in multiply pre-treated metastatic colorectal adenocarcinoma-experience from a tertiary cancer centre in India.
  •  Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant.
  •  Original research article describing a unique approach for gall bladder Carcinoma.
  •  Modified 5-Fluorouracil / Leucovorin / Irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric Cancers.
  •  Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus
  •  Docetaxel in recurrent head and neck cancer.
  •  Bleomycin-induced skin rash.
  •  NUT Midline Carcinoma.

PATIENT SUCCESS STORIES

 
Scroll to Top